Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-11

FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for diltiazem hydrochloride from Actavis Pharma, Inc., confirming/expanding the product's regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride (Diltiazem hydrochloride)

Snippet

SUPPL AP for DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)